TipRanks on MSN

Regeneron’s Cemiplimab Study: Real-World Insights and Market Impact

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: The Cemiplimab Survivorship Epidemiology ...
ascopubs.org

CemiplimAb-rwlc survivorship and epidemiology (CASE): Interim results from a prospective study of the safety and effectiveness of cemiplimab in patients with advanced cutaneous ...

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: Results from a global multi-site chart review. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
ascopubs.org

Chemotherapy Use, Outcomes, and Costs for Older Persons With Advanced Non–Small-Cell Lung Cancer: Evidence From Surveillance, Epidemiology and End Results–Medicare

Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare Patients with locally advanced or metastatic (TNM system ...